Comparative analysis of three antifungal susceptibility test methods against prospectively collected Candida species

Kara M. Villareal, Rebecca A. Cook, John N Galgiani, Richard P. Wenzel, Peter G. Pappas, John C. Pottage, Harry A. Gallis, Lawrence R. Crane

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

We performed antifungal susceptibility tests with cilofungin (LY121019), amphotericin B, and flucytosine against 38 strains of yeasts from patients with esophagitis or fungemia either before, during, or after treatment with cilofungin. Tests were performed using a macrobroth dilution method similar to that proposed by the National Committee for Clinical Laboratory Standards (M27-P) and two microbroth methods. For cilofungin and amphotericin B, minimum inhibitory concentrations from microbroth tests using Antibiotic Medium 3 (AM3) were systematically lower than results from the other two methods that utilized RPMI-1640 medium (RPMI). AM3 did not provide any greater degree of in vitro correlation with clinical results than did RPMI. We conclude that cilofungin and possibly other congeners of the echinocandin class of antifungal agents can effectively be studied using the proposed National Committee for Clinical Laboratory Standards method.

Original languageEnglish (US)
Pages (from-to)89-94
Number of pages6
JournalDiagnostic Microbiology and Infectious Disease
Volume18
Issue number2
DOIs
StatePublished - 1994

Fingerprint

cilofungin
Candida
Amphotericin B
Echinocandins
Fungemia
Anti-Bacterial Agents
Flucytosine
Esophagitis
Antifungal Agents
Microbial Sensitivity Tests
Yeasts

ASJC Scopus subject areas

  • Applied Microbiology and Biotechnology
  • Immunology
  • Microbiology
  • Parasitology
  • Virology
  • Immunology and Allergy
  • Infectious Diseases

Cite this

Comparative analysis of three antifungal susceptibility test methods against prospectively collected Candida species. / Villareal, Kara M.; Cook, Rebecca A.; Galgiani, John N; Wenzel, Richard P.; Pappas, Peter G.; Pottage, John C.; Gallis, Harry A.; Crane, Lawrence R.

In: Diagnostic Microbiology and Infectious Disease, Vol. 18, No. 2, 1994, p. 89-94.

Research output: Contribution to journalArticle

Villareal, Kara M. ; Cook, Rebecca A. ; Galgiani, John N ; Wenzel, Richard P. ; Pappas, Peter G. ; Pottage, John C. ; Gallis, Harry A. ; Crane, Lawrence R. / Comparative analysis of three antifungal susceptibility test methods against prospectively collected Candida species. In: Diagnostic Microbiology and Infectious Disease. 1994 ; Vol. 18, No. 2. pp. 89-94.
@article{e2d52db759934d0cbe058e97e8f7a5d8,
title = "Comparative analysis of three antifungal susceptibility test methods against prospectively collected Candida species",
abstract = "We performed antifungal susceptibility tests with cilofungin (LY121019), amphotericin B, and flucytosine against 38 strains of yeasts from patients with esophagitis or fungemia either before, during, or after treatment with cilofungin. Tests were performed using a macrobroth dilution method similar to that proposed by the National Committee for Clinical Laboratory Standards (M27-P) and two microbroth methods. For cilofungin and amphotericin B, minimum inhibitory concentrations from microbroth tests using Antibiotic Medium 3 (AM3) were systematically lower than results from the other two methods that utilized RPMI-1640 medium (RPMI). AM3 did not provide any greater degree of in vitro correlation with clinical results than did RPMI. We conclude that cilofungin and possibly other congeners of the echinocandin class of antifungal agents can effectively be studied using the proposed National Committee for Clinical Laboratory Standards method.",
author = "Villareal, {Kara M.} and Cook, {Rebecca A.} and Galgiani, {John N} and Wenzel, {Richard P.} and Pappas, {Peter G.} and Pottage, {John C.} and Gallis, {Harry A.} and Crane, {Lawrence R.}",
year = "1994",
doi = "10.1016/0732-8893(94)90071-X",
language = "English (US)",
volume = "18",
pages = "89--94",
journal = "Diagnostic Microbiology and Infectious Disease",
issn = "0732-8893",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Comparative analysis of three antifungal susceptibility test methods against prospectively collected Candida species

AU - Villareal, Kara M.

AU - Cook, Rebecca A.

AU - Galgiani, John N

AU - Wenzel, Richard P.

AU - Pappas, Peter G.

AU - Pottage, John C.

AU - Gallis, Harry A.

AU - Crane, Lawrence R.

PY - 1994

Y1 - 1994

N2 - We performed antifungal susceptibility tests with cilofungin (LY121019), amphotericin B, and flucytosine against 38 strains of yeasts from patients with esophagitis or fungemia either before, during, or after treatment with cilofungin. Tests were performed using a macrobroth dilution method similar to that proposed by the National Committee for Clinical Laboratory Standards (M27-P) and two microbroth methods. For cilofungin and amphotericin B, minimum inhibitory concentrations from microbroth tests using Antibiotic Medium 3 (AM3) were systematically lower than results from the other two methods that utilized RPMI-1640 medium (RPMI). AM3 did not provide any greater degree of in vitro correlation with clinical results than did RPMI. We conclude that cilofungin and possibly other congeners of the echinocandin class of antifungal agents can effectively be studied using the proposed National Committee for Clinical Laboratory Standards method.

AB - We performed antifungal susceptibility tests with cilofungin (LY121019), amphotericin B, and flucytosine against 38 strains of yeasts from patients with esophagitis or fungemia either before, during, or after treatment with cilofungin. Tests were performed using a macrobroth dilution method similar to that proposed by the National Committee for Clinical Laboratory Standards (M27-P) and two microbroth methods. For cilofungin and amphotericin B, minimum inhibitory concentrations from microbroth tests using Antibiotic Medium 3 (AM3) were systematically lower than results from the other two methods that utilized RPMI-1640 medium (RPMI). AM3 did not provide any greater degree of in vitro correlation with clinical results than did RPMI. We conclude that cilofungin and possibly other congeners of the echinocandin class of antifungal agents can effectively be studied using the proposed National Committee for Clinical Laboratory Standards method.

UR - http://www.scopus.com/inward/record.url?scp=0028214218&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028214218&partnerID=8YFLogxK

U2 - 10.1016/0732-8893(94)90071-X

DO - 10.1016/0732-8893(94)90071-X

M3 - Article

C2 - 8062537

AN - SCOPUS:0028214218

VL - 18

SP - 89

EP - 94

JO - Diagnostic Microbiology and Infectious Disease

JF - Diagnostic Microbiology and Infectious Disease

SN - 0732-8893

IS - 2

ER -